dpp-4 inhibitor and glp-1 receptor agonist combination not recommended ada Lesson: A Clinical Overview of Inhibitors for Type 2 Diabetes DPP-4 inhibitors and GLP-1RAs: cardiovascular

Basic research in PCOS: Are we reaching new frontiers

External resources PubMed - Weight regain after GLP-1 RA interruption: narrative review eClinicalMedicine - Metabolic rebound after GLP-1 RA discontinuation: meta-analysis For researchers navigating the complexities of GLP-1 treatment duration, SeekPeptides provides comprehensive protocol guides, dosing calculators , and evidence-based resources designed to help you make informed decisions about your treatment timeline

Trials investigating newer potential anti-obesity medications, including co-agonists and tri-agonists that target peptides such as GLP-1, glucose-dependent insulinotropic polypeptide (GIP), amylin, and glucagon are underway

Finally, I started asking all my doctors, from my PCP to my oncologist to my cardiologist, whether I should consider a GLP-1 drug such as Ozempic/Wegovy (semaglutide) or Mounjaro/Zepbound (tirzepitide)

By end user, the retail pharmacies segment held the dominating share of 51% in the market in 2025

Here's How Weight-Loss